SANDERS MACHELLE 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Nov 17, 2025
Insider Transaction Report
Form 4
SANDERS MACHELLE
Director
Transactions
- Sale
Common Stock
2025-11-13$7.14/sh−9,600$68,544→ 30,642 total
Footnotes (1)
- [F1]These shares were sold pursuant to a plan adopted by the Reporting Person on August 14, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The sale occurred automatically and does not represent a discretionary transaction by the Reporting Person.